Case study involving animal research at the University of Glasgow - Pioneering new treatment for Epilepsy in Dogs
A groundbreaking, first-of-its-kind clinical trial in dogs could offer new hope for pets and their owners impacted by canine epilepsy
Led by researchers at the University of Glasgow’s Small Animal Hospital in collaboration with the Royal College of Surgeons in Ireland, the METriC (MiRNA-134 -antisense-oligonucleotide Epilepsy Treatment in Canines) trial, hopes to successfully treat dogs with severe epilepsy with a new medication, Ant-134. So far, results from the trial have been encouraging, with some of the dogs experiencing a reduction of symptoms and an improved quality of life.
Further details on the study can be found here https://www.gla.ac.uk/news/headline_1054173_en.html